Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-25-000008

CHIEF FINANCIAL OFFICER acquired 173,913 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parker Geoffrey M. · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Grant or award : show line 1 in the form +173,913 1,305,901 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-24 Grant or award : show line 2 in the form Stock Option (Right to buy) +614,844 614,844 D
Loading xslF345X05/wk-form4_1738113304.xml…